Merck And Co Inc 's Revenue in the fiscal year 2025 $ 65,011.00 millions
Merck And Co Inc 's Revenue in the fiscal year 2024 $ 64,168.00 millions
Merck And Co Inc 's Revenue in the fiscal year 2023 $ 60,115.00 millions
Merck And Co Inc 's Revenue in the fiscal year 2022 $ 59,283.00 millions
Merck And Co Inc 's Revenue in the fiscal year 2021 $ 48,704.00 millions
MRK Revenue third quarter 2026 Y/Y Growth Comment
Merck and Co Inc reported Revenue growth of 4.68% year on year in the third quarter 2026, to $ 18,085.00 millions, this is lower than Merck And Co Inc 's recent average Revenue growth of 6.49%.
Looking into third quarter 2026 results within Major Pharmaceutical Preparations industry 120 other companies have achieved higher Revenue growth. While Merck And Co Inc ' s Revenue increase of 4.68% ranks overall at the positon no. 2341 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Merck And Co Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
66.84 %
1.7 %
-22.43 %
(Dec. 30, 2009)
MRK's III. Quarter Q/Q Revenue Comment
Merck and Co Inc achieved in the III. Quarter 2026 above company average sequential Revenue increase of 8.9%, to $ 18,085.00 millions, from $16,607.00 millions in the second quarter.
Within Major Pharmaceutical Preparations industry 57 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 888.
Merck and Co Inc achieved in the III. Quarter 2026 above company average sequential Revenue increase of 8.9%, to $ 18,085.00 millions, from $16,607.00 millions in the second quarter.
Within Major Pharmaceutical Preparations industry 57 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 888.
Merck And Co Inc 's 12 Months Revenue Growth Year on Year
Although Merck And Co Inc 's Annual Revenue growth year on year were below company's average 6.15% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 4.64% year on year, from 2.89% in Mar 31 2026.
In the Healthcare sector 350 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2360, from total ranking in previous quarter at 2857.
Although Merck And Co Inc 's Annual Revenue growth year on year were below company's average 6.15% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 4.64% year on year, from 2.89% in Mar 31 2026.
In the Healthcare sector 350 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2360, from total ranking in previous quarter at 2857.
About Merck And Co Inc Revenue Growth Rates (MRK), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
8.17%